ArticleLeukemia2026

Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability.

V S S Abhinav Ayyadevara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.